Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Retatrutide , a triple-action peptide (GIP/GLP-1/glucagon receptor agonist), is in late-stage clinical trials and has shown even more dramatic weight loss results than tirzepatide
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
Important safety considerations include risks of pancreatitis, hypoglycemia (when used with insulin or insulin secretagogues), acute kidney injury from dehydration, and gallbladder disease
Studies have shown that tirzepatide offers greater weight loss benefits than Ozempic , making it a more powerful option for patients focusing on fat loss
Weight LossOur weight loss programs are medically personalized from the start
US$ 24.72
US$ 27.53
US$ 21.42
US$ 24.01
US$ 27.66
US$ 29.62
US$ 27.69
